Je‐Hwan Lee

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Dae‐Young Kim, Young‐Don Joo, Sung-Nam Lim et al. · Blood · 2015 · 184 citations · Full text

Medicine, Oncology, Pharmacology +11

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Je‐Hwan Lee, Young‐Don Joo, Hawk Kim et al. · Blood · 2011 · 147 citations · Full text

Medicine, Hematology, Oncology +14

Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study

Inpyo Choi, Suk Ran Yoon, Hanna Kim et al. · Biology of Blood and Marrow Transplantation · 2014 · 136 citations · Full text

Medicine, Hematology, Immunology +16